Vaccines against Covid-19 He led at least nine people to become billionairesOxfam, like the French head of Moderna Lab, said Stephane Bancel, whose accumulated wealth will allow him to pollinate the poorest countries
Those new fortunes It arose “thanks to the huge profits of the pharmaceutical groups that have a monopoly on vaccine production “Oxfam said in a statement issued before the G20 health summit in Rome.”
The figures are based on the classification of the American Forbes magazine and its publication by the “People’s Vaccine Alliance”, of which Oxfam is part, and which It brings together organizations and personalities that are calling for free anti-virus vaccines around the world.
The accumulated wealth of the aforementioned nine billionaires – $ 19,300 million –It will be allowed 1.3 times to vaccinate all low-income countriesWhich “received only 0.2 percent of the vaccines produced in the world,” according to Oxfam.
Fortune Group Premium are the president of Moderna, Stephan Bansel, who has $ 4.3 billion, and the president and co-founder of BioNTech, Ujur Shaheen, with $ 4 billion.
Other billionaires are in the pharmaceutical industries They hold cumulative increases in their assets of $ 32,200 million“It is sufficient to vaccinate the entire population of India,” the statement added.
“These vaccines were funded with public money It should be, in the first place, a global public goodSandra Lot-Fernandez, of the French Oxfam, called for “an urgent end to these monopolies.”
European Commission Confirmed that the European Union will be “constructive” in the World Trade Organization (WTO) At the time of evaluation of a survey of antiviral vaccines, requested by Washington.
However, he made it clear He will first propose measures to allow for a rapid increase in production Of vaccinations.
The day before, African and European countries and others, as well as international organizations present at a meeting in Paris on African economies, And they demanded that the patents for anti-virus vaccines be raised to allow them to be produced in Africa.
Nevertheless, “the main members of the G20, such as the United Kingdom and Germany, They continue to block initiatives aimed at lifting “intellectual property” barriers to vaccinesOxfam, which also indicated an “ambiguous position” on the part of France, denounced this.